Subscribe: Medical Pharmaceuticals
http://rss.prnewswire.com/industry/mtc
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced  clinical  company  european  march prnewswire  march  medical  nasdaq  prnewswire  today announced  today  treatment  year 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Medical Pharmaceuticals

PR Newswire: Medical Pharmaceuticals



Press Releases from PR Newswire about Medical Pharmaceuticals



Published: Fri, 24 Mar 2017 00:18:30 EDT

Last Build Date: Fri, 24 Mar 2017 00:01:00 EDT

 



TB Alliance Sublicenses Promising Anti-tuberculosis Drug from the Medicines Patent Pool

Fri, 24 Mar 2017 00:01:00 EDT

(image) NEW YORK and GENEVA, March 24, 2017 /PRNewswire/ -- Agreement announced on World Tuberculosis Day revitalizes efforts to develop sutezolid as effective response to infectious disease killer On World Tuberculosis Day, TB Alliance and the Medicines Patent Pool (MPP) announced a...



Media Files:
http://photos.prnewswire.com/prn/20160706/813286




Surgery Without the Knife: Mirabilis Medical Announces European Approval for Non-Invasive Uterine Fibroid Treatment

Thu, 23 Mar 2017 21:15:00 EDT

(image) BOTHELL, Wash., March 23, 2017 /PRNewswire/ -- Mirabilis Medical, a Seattle-area developer of advanced medical technology for non-invasive surgery, announced today CE Mark authorization for marketing of the Mirabilis System for treatment of uterine fibroids throughout the European Union. ...



Media Files:
https://mma.prnewswire.com/media/482119/Mirabilis_Medical.jpg




Provectus Biopharmaceuticals Announces Terms Of Definitive Financing Commitment

Thu, 23 Mar 2017 17:55:00 EDT

(image) KNOXVILLE, Tenn., March 23, 2017 /PRNewswire/ -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com) ("Provectus" or the "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, today disclosed terms of the previously announced Definitive...



Media Files:
https://mma.prnewswire.com/media/463049/Provectus_Biopharmaceuticals_Logo.jpg




FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma

Thu, 23 Mar 2017 17:30:00 EDT

(image) ROCKLAND, Mass. and NEW YORK, March 23, 2017 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has approved BAVENCIO® (avelumab) Injec...



Media Files:
http://www.emdserono.com




Les innovations précoces confortent une attitude positive lors de la conférence BIO-Europe Spring® 2017 à Barcelone

Thu, 23 Mar 2017 17:11:00 EDT

CARLSBAD, Californie et BARCELONE, Espagne, March 23, 2017 /PRNewswire/ -- La 11e édition annuelle de la conférence internationale sur les partenariats BIO-Europe Spring® s'est achevée cette semaine à Barcelone, en Espagne, et a vu plus de 2 500 cadres dirigeants du secteur des...



Icertis Extends Leadership in Pharmaceutical Market with Update to Clinical Trial Agreement and Budgeting Solution

Thu, 23 Mar 2017 17:00:00 EDT

(image) BELLEVUE, Wash., March 23, 2017 /PRNewswire/ -- Icertis, the leading provider of enterprise contract management in the cloud, today announced an upgrade to the Icertis Clinical Trial Agreement and Budgeting solution designed to improve clinical trials contract management. Built on the...



Media Files:
https://mma.prnewswire.com/media/371539/picture1_Logo.jpg




Digital Pharmacist Acquires PocketRx App

Thu, 23 Mar 2017 16:37:00 EDT

(image) AUSTIN, Texas, March 23, 2017 /PRNewswire/ -- Digital Pharmacist Inc. (www.digitalpharmacist.com), a rapidly growing digital health company, announced today that it has acquired PocketRx, a mobile app that allows patients to manage their prescriptions. Over three hundred pharmacy brands...



Media Files:
https://mma.prnewswire.com/media/482032/PocketRx_Mobile_App.jpg




Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its Website

Thu, 23 Mar 2017 16:10:00 EDT

(image) IRVINE, Calif., March 23, 2017 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that its Annual Report on Form 20-F, containing audited consolidated financial statements for the year ended December 31, 2016, as filed with the...



Media Files:
http://www.syneron-candela.com




Harvard Medical School Names Bill Geary to Department of Biomedical Informatics Advisory Council

Thu, 23 Mar 2017 16:08:00 EDT

(image) BOSTON, March 23, 2017 /PRNewswire/ -- The Department of Biomedical Informatics at Harvard Medical School has named Bill Geary to its advisory council. Geary joins a group of distinguished individuals and thought leaders charged with advising department chair Isaac Kohane as he scales up...



Media Files:
https://mma.prnewswire.com/media/481937/Harvard_Medical_School___Brian_Geary.jpg




BioPharmX Reports Fourth Quarter and Full Year 2017 Financial Results

Thu, 23 Mar 2017 16:05:00 EDT

(image) MENLO PARK, Calif., March 23, 2017 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today reported financial results for the quarter and year ended Jan. 31, 2017, and will provide an update on the...



Media Files:
https://mma.prnewswire.com/media/479019/BioPharmX_Corporation_Logo.jpg




Topsalysin Data from Successful Phase 2a Localized Prostate Cancer Study to be Presented at the 32nd European Association of Urology Congress

Thu, 23 Mar 2017 16:05:00 EDT

(image) SAN DIEGO and VANCOUVER, British Columbia, March 23, 2017 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a clinical late-stage biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases, today announced that data from...



Media Files:
https://mma.prnewswire.com/media/441889/Sophiris_Bio_Inc_Logo.jpg




GlobeImmune Announces Majority Stock Sale

Thu, 23 Mar 2017 16:03:00 EDT

(image) LOUISVILLE, Colo., March 23, 2017 /PRNewswire/ -- GlobeImmune, Inc. today announced it has entered into a definitive purchase agreement for the sale of 12,835,490 shares of its common stock to NantCell, Inc., a member of the NantWorks ecosystem of companies. In connection with th...



Media Files:
http://www.globeimmune.com




Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2016

Thu, 23 Mar 2017 16:00:00 EDT

(image) NASDAQ, TSX: NVCN VANCOUVER, March 23, 2017 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced financial results for the quarter and year ended December 31, 2016 (all figures in U.S. dollars unless otherwise indicated). "While the ongoing...



Media Files:
www.neovasc.com




European Commission Approves AMGEVITA™ (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases

Thu, 23 Mar 2017 16:00:00 EDT

(image) THOUSAND OAKS, Calif., March 23, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted marketing authorization for AMGEVITA™ (biosimilar adalimumab1) in all available indications. AMGEVITA is authorized for the treatment of certain...



Media Files:
https://mma.prnewswire.com/media/213782/amgen_logo.jpg




Physicians Committee Hosts Fifth-Annual International Conference on Nutrition in Medicine in Washington, D.C., on July 28 to 29, 2017

Thu, 23 Mar 2017 16:00:00 EDT

(image) WASHINGTON, March 23, 2017 /PRNewswire-USNewswire/ -- Diet-related risk factors account for nearly half, more than 300,000, cardiometabolic deaths each year related to heart disease, stroke, and diabetes. Eight-six percent of doctors feel uncomfortable talking to patients about diet and...



Media Files:
https://mma.prnewswire.com/media/482026/Physicians_Committee_International_Conference_on_Nutrition_in_Medicine.jpg




Mississippi Health Professionals Receive Advanced Wound Care Training Aimed To Reduce Patient Harm

Thu, 23 Mar 2017 15:59:00 EDT

(image) PLAINFIELD, Ill., March 23, 2017 /PRNewswire-USNewswire/ -- Wound Care Education Institute® (WCEI®), leading provider of comprehensive education in skin, wound, diabetic and ostomy management, offered onsite skin and wound management training in partnership with the Mississippi Hospital...



Media Files:
https://mma.prnewswire.com/media/345727/wcei_logo_vectr_cmyk_logo_Logo.jpg




BioSpace Releases BioIndiana Hotbed Map

Thu, 23 Mar 2017 15:40:00 EDT

(image) DES MOINES, Iowa, March 23, 2017 /PRNewswire/ -- BioSpace, the leading biotechnology and pharmaceutical industry news and career resource, has partnered with Indiana Biosciences Research Institute and over 20 dynamic Indiana organizations and educational institutions to bring the state's...



Media Files:
https://mma.prnewswire.com/media/53867/biospace_logo.jpg




Primary Hyperoxaluria - Pipeline Review, H1 2017

Thu, 23 Mar 2017 14:51:00 EDT

(image) LONDON, March 23, 2017 /PRNewswire/ -- SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Hyperoxaluria - Pipeline Review, H1 2017, provides an overview of the Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) pipeline...



Media Files:
http://www.reportbuyer.com




FDA approves first treatment for rare form of skin cancer

Thu, 23 Mar 2017 14:49:00 EDT

(image) SILVER SPRING, Md., March 23, 2017 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those...



Media Files:
https://mma.prnewswire.com/media/317925/fdalogo_black_Logo.jpg




Merck Manuals Dispels Multiple Sclerosis Myths

Thu, 23 Mar 2017 14:24:00 EDT

(image) KENILWORTH, N.J., March 23, 2017 /PRNewswire/ -- Though multiple sclerosis (MS) is one of the most common diseases affecting the central nervous system, misconceptions and outdated stereotypes about the condition persist. Ten thousand new cases are diagnosed every year, yet relatively...



Media Files:
https://www.merckmanuals.com